Skip to content

Author

Ricard Cervera

We have 2 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Deep clinical renal response in lupus nephritis treated with belimumab: a real-world cohort study.

OBJECTIVES Lupus nephritis (LN) often progresses despite therapy, and current complete renal response (CRR) definitions tolerate residual proteinuria deemed suboptimal in other glomerulopathies. Belimumab, the first biologic approved for active LN, may enable deeper remission, but its real-world effectiveness is unknow...

Marc Xipell, M. C. Garbarino, I. Rodríguez-Pintó et al. · 0 citations
Review Open access Sep 2026

Revisiting the Interferon Axis in Systemic and Cutaneous Lupus Erythematosus: From Targeted Therapy to Real-World Clinical Practice.

For many years, systemic lupus erythematosus (SLE) pathogenesis was interpreted primarily through the lens of adaptive immunity, with emphasis on disruption of T- and B-cell tolerance, autoantibody production, immune-complex deposition, and complement activation. However, a major shift in the understanding of SLE immun...

Marina Selva-Del Río, Pablo Balado-Simó, X. Bosch-Amate et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.